Aaron R. Weiss

Hematology | Oncology
22 Bramhall St
Portland, ME 04102

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications

Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

Omitting Bone Marrow Sampling in FDG-Avid Rhabdomyosarcoma With 2-[18F]FDG PET-Negative Marrow: Results From an International Retrospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 24, 2026

Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children's oncology group ARST0332 trial.

Outcome of metastatic non-rhabdomyosarcoma soft tissue sarcoma in children and young adults treated on children's oncology group ARST0332 trial.

Journal: Journal of the National Cancer Institute
Published: March 11, 2026

Alveolar Soft Part Sarcoma in Pediatric and Young Adult Patients: A Report From the Children's Oncology Group Study ARST0332.

Alveolar Soft Part Sarcoma in Pediatric and Young Adult Patients: A Report From the Children's Oncology Group Study ARST0332.

Journal: Pediatric blood & cancer
Published: September 05, 2025

Malignant peripheral nerve sheath tumors: a report from Children's Oncology Group study ARST0332.

Malignant peripheral nerve sheath tumors: a report from Children's Oncology Group study ARST0332.

Journal: Journal of the National Cancer Institute
Published: September 03, 2025

Current Approaches to the Treatment of Pediatric Soft Tissue Sarcomas: Rhabdomyosarcoma and Nonrhabdomyosarcoma Soft Tissue Sarcomas.

Current Approaches to the Treatment of Pediatric Soft Tissue Sarcomas: Rhabdomyosarcoma and Nonrhabdomyosarcoma Soft Tissue Sarcomas.

Journal: Hematology/oncology clinics of North America
Published: May 15, 2025

Regional lymph node invasion in pediatric non-rhabdomyosarcoma soft tissue sarcoma: an international cohort study from the International Soft Tissue Sarcoma Consortium.

Regional lymph node invasion in pediatric non-rhabdomyosarcoma soft tissue sarcoma: an international cohort study from the International Soft Tissue Sarcoma Consortium.

Journal: EClinicalMedicine
Published: May 09, 2025

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.

Prioritization of novel agents for further investigation in pediatric non-rhabdomyosarcoma soft tissue sarcomas: A report from the Children's Oncology Group.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 14, 2025

Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials.

Journal: Cancer
Published: June 28, 2024

Current Management of Desmoid Tumors: A Review.

Current Management of Desmoid Tumors: A Review.

Journal: JAMA oncology
Published: June 20, 2024

Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.

Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332.

Journal: Pediatric blood & cancer
Published: February 16, 2024

Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.

Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.

Journal: Pediatric blood & cancer
Published: January 18, 2024

Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group.

Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group.

Journal: Cancer
Published: December 07, 2023
Showing 1-12 of 55

Last Updated: 09/26/2026